AMCP webinar that addressed what is currently being seen in the industry and how to effectively support and continue this early, meaningful, and effective exchange of information for pre-approval products.
AMCP has released Version 4.1 of the AMCP Format for Formulary Submissions, which includes two new dossier types for biopharmaceutical manufacturers to share evidence on unapproved products and new indications that are under review by the U.S. Food and Drug Administration (FDA).
Press Release: "Precision medicine is no longer emerging, it's happening now," according to Susan A. Cantrell, RPh, CAE, CEO of the Academy of Managed Care Pharmacy (AMCP).
Partnership Forum: Industry leaders gather together on September 13-14, 2016 to develope recommendations for biopharmaceutical companies and health care decision makers to more easily communicate information on products awaiting FDA approval.
Press Release: The Academy of Managed Care Pharmacy (AMCP) today released a set of recommendations that would allow biopharmaceutical companies to more easily share health care economic information (HCEI) with entities that make formulary and coverage decisions.
AMCP webinar that provided an overview of key updates to the Format, Version 4.0, including new guidance related to emerging special topic considerations such as biosimilars, specialty drugs, and companion diagnostic tests.
